{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:41:21Z","timestamp":1790138481355,"version":"4.0.1"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22wm0325015, JP22jm0210074"],"award-info":[{"award-number":["JP22wm0325015, JP22jm0210074"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20240141"],"award-info":[{"award-number":["JP20240141"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Human T-cell leukemia virus type 1 (HTLV-1), a retrovirus which mainly infects CD4<jats:sup>+<\/jats:sup>T cells and causes adult T-cell leukemia\/lymphoma (ATL), is primarily transmitted<jats:italic>via<\/jats:italic>direct cell-to-cell transmission. This feature generates a wide variety of infected clones in hosts, which are maintained<jats:italic>via<\/jats:italic>clonal proliferation, resulting in the persistence and survival of the virus. The maintenance of the pool of infected cells is achieved by sculpting the immunophenotype of infected cells and modulating host immune responses to avoid immune surveillance. Here, we review the processes undertaken by HTLV-1 to modulate and subvert host immune responses which contributes to viral persistence and development of ATL.<\/jats:p>","DOI":"10.3389\/fimmu.2022.991928","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T05:38:52Z","timestamp":1665380332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system"],"prefix":"10.3389","volume":"13","author":[{"given":"Benjy J. Y.","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sugata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorifumi","family":"Satou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type c retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-2-17","article-title":"The discovery of the first human retrovirus: HTLV-1 and HTLV-2","volume":"2","author":"Gallo","year":"2005","journal-title":"Retrovirology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1521629112","article-title":"The discovery of HTLV-1, the first pathogenic human retrovirus","volume":"112","author":"Coffin","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V50.3.481.481","article-title":"Adult T-cell leukemia: clinical and hematologic features of 16 cases","volume":"50","author":"Uchiyama","year":"1977","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-2-16","article-title":"Discovery of adult T-cell leukemia","volume":"2","author":"Takatsuki","year":"2005","journal-title":"Retrovirology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00124-13","article-title":"Viruses and human cancers: A long road of discovery of molecular paradigms","volume":"27","author":"White","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.12688\/f1000research.17479.1","article-title":"40 years of the human T-cell leukemia virus: past, present, and future","volume":"8","author":"Tagaya","year":"2019","journal-title":"F1000Research"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","article-title":"Human T cell leukemia virus type 1: Persistence and pathogenesis","volume":"36","author":"Bangham","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis","volume":"326","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"327","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.18.8461-8468.2001","article-title":"Examining human T-lymphotropic virus type 1 infection and replication by cell-free infection with recombinant virus vectors","volume":"75","author":"Derse","year":"2001","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1080115","article-title":"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","volume":"299","author":"Igakura","year":"2003","journal-title":"Sci (80- )"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2065","article-title":"Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses","volume":"16","author":"Pais-Correia","year":"2010","journal-title":"Nat Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1010126","article-title":"M-sec induced by HTLV-1 mediates an efficient viral transmission","volume":"17","author":"Hiyoshi","year":"2021","journal-title":"PloS Pathog"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199600001-00016","article-title":"Clonal expansion of infected cells: A way of life for HTLV-I","volume":"13","author":"Wattel","year":"1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pcbi.1007470","article-title":"The relative contributions of infectious and mitotic spread to HTLV-1 persistence","volume":"16","author":"Laydon","year":"2020","journal-title":"PloS Comput Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208970","article-title":"Cellular immune response to HTLV-1","volume":"24","author":"Bangham","year":"2005","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939451","article-title":"CTL quality and the control of human retroviral infections","volume":"39","author":"Bangham","year":"2009","journal-title":"Eur J Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/v3081374","article-title":"HTLV-1 and innate immunity","volume":"3","author":"Journo","year":"2011","journal-title":"Viruses"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2012.00323","article-title":"The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases","volume":"3","author":"Kannagi","year":"2012","journal-title":"Front Microbiol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-019-0498-6","article-title":"Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1","volume":"16","author":"Forlani","year":"2019","journal-title":"Retrovirology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.3390\/v14081611","article-title":"Is the HTLV-1 retrovirus targeted by host restriction factors","volume":"14","author":"Carcone","year":"2022","journal-title":"Viruses"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2020.00421","article-title":"The role of chemokines in the pathogenesis of HTLV-1","volume":"11","author":"Zargari","year":"2020","journal-title":"Front Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13223-018-0278-1","article-title":"An introduction to immunology and immunopathology","volume":"14","author":"Marshall","year":"2018","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-015-0236-7","article-title":"Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients","volume":"13","author":"Cook","year":"2016","journal-title":"Retrovirology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0272","article-title":"Human T-cell leukaemia virus type 1: Parasitism and pathogenesis","volume":"372","author":"Bangham","year":"2017","journal-title":"Philos Trans R Soc B Biol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.010199-0","article-title":"HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes","volume":"90","author":"Suemori","year":"2009","journal-title":"J Gen Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001117","article-title":"HLA class I binding of HBZ determines outcome in HTLV-1 infection","volume":"6","author":"MacNamara","year":"2010","journal-title":"PloS Pathog"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208973","article-title":"Transcriptional and post-transcriptional gene regulation of HTLV-1","volume":"24","author":"Kashanchi","year":"2005","journal-title":"Oncogene"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nm984","article-title":"HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication","volume":"10","author":"Nicot","year":"2004","journal-title":"Nat Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M803116200","article-title":"An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300\/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ","volume":"283","author":"Clerc","year":"2008","journal-title":"J Biol Chem"},{"key":"B34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.12688\/wellcomeopenres.12469.2","article-title":"Single-cell heterogeneity and cell-cycle-related viral gene bursts in the human leukaemia virus HTLV-1","volume":"2","author":"Billman","year":"2017","journal-title":"Wellcome Open Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-2-64","article-title":"Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms","volume":"2","author":"Taniguchi","year":"2005","journal-title":"Retrovirology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/wellcomeopenres.14741.2","article-title":"Epigenetic changes around the pX region and spontaneous HTLV-1 transcription are CTCF-independent [version 2; referees: 2 approved]","volume":"3","author":"Miura","year":"2018","journal-title":"Wellcome Open Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1423199113","article-title":"The retrovirus HTLV-1 inserts an ectopic CTCF-binding site into the human genome","volume":"113","author":"Satou","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-30029-9","article-title":"Identification and characterization of a novel enhancer in the HTLV-1 proviral genome","volume":"13","author":"Matsuo","year":"2022","journal-title":"Nat Commun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1715724115","article-title":"Sporadic on\/off switching of HTLV-1 tax expression is crucial to maintain the whole population of virus-induced leukemic cells","volume":"115","author":"Mahgoub","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells","volume":"103","author":"Satou","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-6-19","article-title":"In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"6","author":"Saito","year":"2009","journal-title":"Retrovirology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/348245a0","article-title":"Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease","volume":"348","author":"Jacobson","year":"1990","journal-title":"Nature"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/3.8.761","article-title":"Predominant recognition of human t cell leukemia virus type i (Htlv-i) px gene products by human cd8 + cytotoxic t cells directed against htlv-l-infected cells","volume":"3","author":"Kannagi","year":"1991","journal-title":"Int Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.5.2928-2933.1992","article-title":"Target epitope in the tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells","volume":"66","author":"Kannagi","year":"1992","journal-title":"J Virol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.5.2860-2868.1994","article-title":"Circulating anti-tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously","volume":"68","author":"Parker","year":"1994","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.9.5389","article-title":"Peptide recognition by two HLA-A2\/Tax11-19-specific T cell clones in relationship to their MHC\/peptide\/TCR crystal structures","volume":"162","author":"Hausmann","year":"1999","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.7.3848","article-title":"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-i-associated myelopathy","volume":"96","author":"Jeffery","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7278","article-title":"The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection","volume":"165","author":"Jeffery","year":"2000","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-014-0116-6","article-title":"Cytotoxic T lymphocyte lysis of HTLV-1 infected cells is limited by weak HBZ protein expression, but non-specifically enhanced on induction of tax expression","volume":"11","author":"Rowan","year":"2014","journal-title":"Retrovirology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00661-12","article-title":"Human T-cell leukemia virus type 1 (HTLV-1) bZIP factor requires cellular transcription factor JunD to upregulate HTLV-1 antisense transcription from the 3\u2032 long terminal repeat","volume":"86","author":"Gazon","year":"2012","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.74","article-title":"HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression","volume":"31","author":"Terol","year":"2017","journal-title":"Leukemia"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/7.4.653","article-title":"HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. low proportion of binding motifs for several HLA class I alleles in EBNA-1","volume":"7","author":"Stuber","year":"1995","journal-title":"Int Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.9.7877-7881.1999","article-title":"Human papillomavirus type 16 E7 DNA vaccine: Mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity","volume":"73","author":"Shi","year":"1999","journal-title":"J Virol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12977-020-0511-0","article-title":"HTLV-1 bZIP factor: The key viral gene for pathogenesis","volume":"17","author":"Matsuoka","year":"2020","journal-title":"Retrovirology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.celrep.2019.09.016","article-title":"The nature of the HTLV-1 provirus in naturally infected individuals analyzed by the viral DNA-Capture-Seq approach","volume":"29","author":"Katsuya","year":"2019","journal-title":"Cell Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20007","article-title":"Genetic and epigenetic inactivation of TAX gene in adult t-cell leukemia cells","volume":"109","author":"Takeda","year":"2004","journal-title":"Int J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.10.003","article-title":"Strong correlation between tax and HBZ mRNA expression in HAM\/TSP patients: Distinct markers for the neurologic disease","volume":"56","author":"Andrade","year":"2013","journal-title":"J Clin Virol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4350","article-title":"Preferential selection of human T-cell leukemia virus type I provirus integration sites in leukemic versus carrier states","volume":"106","author":"Doi","year":"2005","journal-title":"Blood"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-312926","article-title":"The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones","volume":"117","author":"Gillet","year":"2011","journal-title":"Blood"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1003271","article-title":"Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection","volume":"9","author":"Melamed","year":"2013","journal-title":"PloS Pathog"},{"key":"B61","doi-asserted-by":"publisher","first-page":"eabm6210","DOI":"10.1126\/sciadv.abm6210","article-title":"Selective clonal persistence of human retroviruses in vivo: Radial chromatin organization, integration site, and host transcription","volume":"8","author":"Melamed","year":"2022","journal-title":"Sci Adv"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-02-553602","article-title":"The role of HTLV-1 clonality, proviral structure, and genomic integration site in adult T-cell leukemia\/lymphoma","volume":"123","author":"Cook","year":"2014","journal-title":"Blood"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.8.3065.bloodjournal8883065","article-title":"Two types of defective human T-lymphotropic virus type I provirus in adult T-cell leukemia","volume":"88","author":"Tamiya","year":"1996","journal-title":"Blood"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02511-06","article-title":"Preferential selection of human T-cell leukemia virus type 1 provirus lacking the 5\u2032 long terminal repeat during oncogenesis","volume":"81","author":"Miyazaki","year":"2007","journal-title":"J Virol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25450","article-title":"Defective human T-lymphotropic virus type 1 provirus in asymptomatic carriers","volume":"128","author":"Takenouchi","year":"2011","journal-title":"Int J Cancer"},{"key":"B66","article-title":"Defective provirus form of human T-cell leukemia virus type I in adult T-cell Leukemia\/Lymphoma: Clinicopathological features","volume":"51","author":"Kimura","year":"1991","journal-title":"Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.10.5471-5476.1991","article-title":"Polymerase chain reaction analysis of defective human T-cell leukemia virus type I proviral genomes in leukemic cells of patients with adult T-cell leukemia","volume":"65","author":"Korber","year":"1991","journal-title":"J Virol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br J Haematol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.25","article-title":"The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma","volume":"21","author":"Karube","year":"2008","journal-title":"Mod Pathol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-118539","article-title":"High frequency of CD4+FoxP3+ cells in HTLV-1 infection: Inverse correlation with HTLV-l-specific CTL response","volume":"111","author":"Toulza","year":"2008","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-9-46","article-title":"HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals","volume":"9","author":"Satou","year":"2012","journal-title":"Retrovirology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00080.x","article-title":"Possible origin of adult T-cell leukemia\/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells","volume":"96","author":"Kohno","year":"2005","journal-title":"Cancer Sci"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326199","article-title":"HTLV-1 bZIP factor enhances TGF-\u03b2 signaling through p300 coactivator","volume":"118","author":"Zhao","year":"2011","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001274","article-title":"HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo","volume":"7","author":"Satou","year":"2011","journal-title":"PloS Pathog"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh366","article-title":"Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells","volume":"18","author":"Chen","year":"2006","journal-title":"Int Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","article-title":"Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells","volume":"99","author":"Shimauchi","year":"2008","journal-title":"Cancer Sci"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.24664","article-title":"FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia","volume":"125","author":"Toulza","year":"2009","journal-title":"Int J Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0044","article-title":"Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1","volume":"2","author":"Koya","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1172\/JCI150472","article-title":"HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia\/ lymphoma","volume":"131","author":"Tan","year":"2021","journal-title":"J Clin Invest"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02876","article-title":"Restriction factors: From intrinsic viral restriction to shaping cellular immunity against HIV-1","volume":"9","author":"Colomer-Lluch","year":"2018","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.it.2007.09.006","article-title":"How does HTLV-I persist despite a strong cell-mediated immune response","volume":"29","author":"Asquith","year":"2008","journal-title":"Trends Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.01.011","article-title":"Complementary function of the two catalytic domains of APOBEC3G","volume":"333","author":"Navarro","year":"2005","journal-title":"Virology"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609444104","article-title":"Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid","volume":"104","author":"Derse","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02239-09","article-title":"APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes In vivo","volume":"84","author":"Fan","year":"2010","journal-title":"J Virol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.11.012","article-title":"Cell-cell transmission allows human T-lymphotropic virus 1 to circumvent tetherin restriction","volume":"436","author":"Ilinskaya","year":"2013","journal-title":"Virology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2013.09.009","article-title":"Host restriction factor SAMHD1 limits human T cell leukemia virus type 1 infection of monocytes via STING-mediated apoptosis","volume":"14","author":"Sze","year":"2013","journal-title":"Cell Host Microbe"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12977-017-0350-9","article-title":"Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"14","author":"Nozuma","year":"2017","journal-title":"Retrovirology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00985","article-title":"Comprehensive antiretroviral restriction factor profiling reveals the evolutionary imprint of the ex vivo and in vivo IFN-\u03b2 response in HTLV-1-associated neuroinflammation","volume":"9","author":"Leal","year":"2018","journal-title":"Front Microbiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.626325","article-title":"MiR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection","volume":"290","author":"Bai","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002665","article-title":"Evolution of retrovirus-infected premalignant T-cell clones prior to adult T-cell leukemia\/lymphoma diagnosis","volume":"135","author":"Rowan","year":"2020","journal-title":"Blood"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat Commun"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/nri1936","article-title":"Cancer despite immunosurveillance: Immunoselection and immunosubversion","volume":"6","author":"Zitvogel","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.608890","article-title":"Phenotypic and functional analyses guiding combination immune checkpoint immunotherapeutic strategies in HTLV-1 infection","volume":"12","author":"Clements","year":"2021","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.11.3.1313-1325.1991","article-title":"Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax","volume":"11","author":"Miura","year":"1991","journal-title":"Mol Cell Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"3992","DOI":"10.1002\/j.1460-2075.1994.tb06715.x","article-title":"Molecular characterization of murine and human OX40\/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34","volume":"13","author":"Baum","year":"1994","journal-title":"EMBO J"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft","year":"2009","journal-title":"Immunol Rev"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006120","article-title":"HTLV-1 bZIP factor enhances T-cell proliferation by impeding the suppressive signaling of Co-inhibitory receptors","volume":"13","author":"Kinosada","year":"2017","journal-title":"PloS Pathog"},{"key":"B99","doi-asserted-by":"publisher","first-page":"393","DOI":"10.15252\/embj.201387725","article-title":"A THEMIS : SHP 1 complex promotes T-cell survival","volume":"34","author":"Paster","year":"2015","journal-title":"EMBO J"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP factor impairs anti-viral immunity by inducing Co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT)","volume":"12","author":"Yasuma","year":"2016","journal-title":"PloS Pathog"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21688","article-title":"Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia\/lymphoma: High interleukin-5 and -10 levels are significant unfavorable prognostic factors","volume":"118","author":"Inagaki","year":"2006","journal-title":"Int J Cancer"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006861","article-title":"Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection","volume":"14","author":"Kagdi","year":"2018","journal-title":"PloS Pathog"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2013.00129","article-title":"Regulation of adaptive immunity; the role of interleukin-10","volume":"4","author":"Ng","year":"2013","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1006597","article-title":"IL-10-mediated signals act as a switch for lymphoproliferation in human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways","volume":"13","author":"Sawada","year":"2017","journal-title":"PloS Pathog"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922884117","article-title":"HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling","volume":"117","author":"Higuchi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23042","article-title":"Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia\/lymphoma","volume":"121","author":"Shimauchi","year":"2007","journal-title":"Int J Cancer"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V110.11.511.511","article-title":"CTL exhaustion in persistent HTLV-1 infection and ATLL is restored through PD-1\/PD-L1 pathway","volume":"110","author":"Kozako","year":"2007","journal-title":"Blood"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200635978","article-title":"Contribution of the PD-1 ligands\/PD-1 signaling pathway to dendritic cell-mediated CD4+ cell activation","volume":"36","author":"Kuipers","year":"2006","journal-title":"Eur J Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-020-03967-x","article-title":"Comprehensive immunohistochemical analysis of immune checkpoint molecules in adult T cell leukemia\/lymphoma","volume":"99","author":"Takeuchi","year":"2020","journal-title":"Ann Hematol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1803181","article-title":"Rapid progression of adult T-cell leukemia\u2013lymphoma after PD-1 inhibitor therapy","volume":"378","author":"Ratner","year":"2018","journal-title":"N Engl J Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002038","article-title":"Rapid progression of adult T-cell leukemia\/lymphoma as tumor-infiltrating tregs after PD-1 blockade","volume":"134","author":"Rauch","year":"2019","journal-title":"Blood"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0361","article-title":"HTLV-1 viral factor HBZ induces CCR4 to promote T-cell migration and proliferation","volume":"76","author":"Sugata","year":"2016","journal-title":"Cancer Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1003630","article-title":"HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression","volume":"9","author":"Yamamoto-Taguchi","year":"2013","journal-title":"PloS Pathog"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903846","article-title":"Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3 + regulatory T cells","volume":"185","author":"Toulza","year":"2010","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J Exp Med"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized aanti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: A randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br J Haematol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003053","article-title":"Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study","volume":"4","author":"Yonekura","year":"2020","journal-title":"Blood Adv"},{"key":"B122","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/cei.13194","article-title":"From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics","volume":"197","author":"Bending","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2017.01764","article-title":"Tolerance through education: How tolerogenic dendritic cells shape immunity","volume":"8","author":"Domogalla","year":"2017","journal-title":"Front Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00813-11","article-title":"Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 tax-1 function and inhibits viral replication","volume":"85","author":"Tosi","year":"2011","journal-title":"J Virol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.03000-15","article-title":"The major histocompatibility complex class II transactivator CIITA inhibits the persistent activation of NF-\u03baB by the human T cell lymphotropic virus type 1 tax-1 oncoprotein","volume":"90","author":"Forlani","year":"2016","journal-title":"J Virol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.12.015","article-title":"Polycomb-mediated loss of miR-31 activates nik-dependent NF-\u03baB pathway in adult T cell leukemia and other cancers","volume":"21","author":"Yamagishi","year":"2012","journal-title":"Cancer Cell"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.991928\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T19:52:12Z","timestamp":1677095532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.991928\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":126,"alternative-id":["10.3389\/fimmu.2022.991928"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.991928","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"991928"}}